These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31017369)

  • 1. Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
    Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC
    Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy.
    Park S; Baek CH; Cho H; Yu MY; Kim YC; Go H; Kim YH; Lee JP; Min SI; Ha J; Moon KC; Kim YS; Ahn C; Park SK; Lee H
    Am J Transplant; 2019 Jan; 19(1):145-155. PubMed ID: 29718591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Oxford Classification in Post-Transplant Immunoglobulin A Nephropathy.
    Agrawal V; Singh A; Kaul A; Verma R; Jain M; Pandey R
    Transplant Proc; 2017 Dec; 49(10):2274-2279. PubMed ID: 29198660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using computer-assisted morphometrics of 5-year biopsies to identify biomarkers of late renal allograft loss.
    Denic A; Morales MC; Park WD; Smith BH; Kremers WK; Alexander MP; Cosio FG; Rule AD; Stegall MD
    Am J Transplant; 2019 Oct; 19(10):2846-2854. PubMed ID: 30947386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.
    Park S; Baek CH; Go H; Kim YH; Min SI; Ha J; Kim YC; Lee JP; Kim YS; Moon KC; Park SK; Lee H
    BMC Nephrol; 2019 Sep; 20(1):354. PubMed ID: 31510954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies.
    Zhang J; Chen GD; Qiu J; Liu GC; Chen LZ; Fu K; Wu ZX
    BMC Nephrol; 2019 Dec; 20(1):446. PubMed ID: 31796001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
    Von Visger JR; Gunay Y; Andreoni KA; Bhatt UY; Nori US; Pesavento TE; Elkhammas EA; Winters HA; Nadasdy T; Singh N
    Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Modified Oxford Score in Recurrent IgA Nephropathy in North American Kidney Transplant Recipients: The Banff Recurrent Glomerulonephritis Working Group Report.
    Alachkar N; Delsante M; Greenberg RS; Koirala A; Alhamad T; Abdalla B; Anand M; Boonpheng B; Blosser C; Maggiore U; Bagnasco SM
    Transplantation; 2023 Sep; 107(9):2055-2063. PubMed ID: 37202854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
    Di Vico MC; Messina M; Fop F; Barreca A; Segoloni GP; Biancone L
    Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Oxford classification in assessing immunoglobulin A nephropathy after transplantation.
    Lim BJ; Joo DJ; Kim MS; Kim YS; Kim SI; Kim Y; Huh KH; Koh MJ; Jeong HJ
    Transplantation; 2013 Jun; 95(12):1491-7. PubMed ID: 23677050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA nephropathy and kidney transplantation according to the Oxford classification.
    Vasconcelos AS; Mazzali M; de Sousa MV
    J Bras Nefrol; 2023; 45(3):350-356. PubMed ID: 36626310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival.
    Eder M; Kozakowski N; Omic H; Aigner C; Kläger J; Perschl B; Reindl-Schwaighofer R; Bond G; Böhmig GA; Kikić Ž
    J Nephrol; 2021 Jun; 34(3):839-849. PubMed ID: 33306182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation.
    Maixnerova D; Hruba P; Neprasova M; Bednarova K; Slatinska J; Suchanek M; Kollar M; Novak J; Tesar V; Viklicky O
    Front Immunol; 2021; 12():726215. PubMed ID: 34659212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation.
    Singh T; Astor BC; Zhong W; Mandelbrot DA; Maursetter L; Panzer SE
    Clin Transplant; 2019 Dec; 33(12):e13738. PubMed ID: 31630440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
    Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
    Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).
    Schimpf JI; Klein T; Fitzner C; Eitner F; Porubsky S; Hilgers RD; Floege J; Groene HJ; Rauen T
    BMC Nephrol; 2018 Nov; 19(1):328. PubMed ID: 30453889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.